Vistra (VST) has formally challenged PJM's Interim Resource Adequacy Service proposal with the Federal Energy Regulatory Commission, arguing the framework is discriminatory and legally flawed. The company contends that this regulatory action could disrupt future investment signals within the PJM region, adding a layer of uncertainty to its operational environment. Despite recent short-term volatility, Vistra maintains strong longer-term momentum, evidenced by a 3-year total shareholder return of approximately 4.7x. However, the stock currently trades at US$144.89, which represents a significant discount to analyst fair value estimates of roughly $291.87. This valuation gap suggests investors are heavily pricing in regulatory risks and GAAP volatility while potentially overlooking underlying cash flow fundamentals. The company's growth narrative relies on three specific, signed catalysts: Cogentrix operations, power purchase agreements with Meta, and the Helix project. Vistra has reaffirmed its 2026 Adjusted Free Cash Flow guidance, explicitly excluding contributions from Cogentrix and the Meta agreements to provide a conservative baseline. Analysts suggest that even accounting for ongoing regulatory disputes in PJM, the stock remains undervalued based on these projected cash flows. Investors face a critical decision regarding whether the current price discount offers a margin of safety or serves as a warning signal for potential returns on new capacity being limited by regulatory outcomes. While hedge-driven GAAP swings continue to erode investor confidence in the short term, the core value proposition rests on the execution of its disclosed contracts and the resolution of the PJM legal challenge.